Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michael Siah, M.D. Medstar Georgetown University Hospital

Similar presentations


Presentation on theme: "Michael Siah, M.D. Medstar Georgetown University Hospital"— Presentation transcript:

1 Common Femoral Artery Disease: When is Endovascular Therapy Appropriate
Michael Siah, M.D. Medstar Georgetown University Hospital Medstar Washington Hospital Center Washington, D.C.

2 Disclosure No financial disclosures

3 Common Femoral Artery Disease
Asymptomatic disease very uncommon Most patients with CLI or severe claudication May be associated with graft occlusion and clot propagation Advanced atherosclerosis

4 Common Femoral Artery Disease
Usually requires intervention Preservation of the profunda is paramount Ostium Distal embolization

5 Common Femoral Artery Disease: Challenges
Anatomy: Location Geometry: Bifurcation Access Difficulty Disease Severity

6 Common Femoral Artery Disease: Challenges
Anatomy: Location Inguinal Ligament Flexion Geometry: Bifurcation Access Difficulty Disease Severity

7 Common Femoral Artery Disease: Challenges
Anatomy: Location Inguinal Ligament Flexion Geometry: Bifurcation SFA, Profunda – Equally important Access Difficulty Disease Severity

8 Common Femoral Artery Disease: Challenges
Anatomy: Location Inguinal Ligament Flexion Geometry: Bifurcation SFA, Profunda – Equally important Access Difficulty Contralateral Femoral, Brachial Disease Severity

9 Common Femoral Artery Disease: Challenges
Anatomy: Location Inguinal Ligament Flexion Geometry: Bifurcation SFA, Profunda – Equally important Access Difficulty Contralateral Femoral, Brachial Disease Severity Inflow Lesion

10 Common Femoral Artery Disease: Percutaneous Endovascular Treatment
POBA Atherectomy Stenting

11 Common Femoral Artery Disease: Rationale for Surgery
POBA Atherectomy Stenting Excellent Results with Surgery

12 Common Femoral Artery Disease: Surgical Options
Endarterectomy Bypass Cross Femoral Bypass Ilio-Femoral Bypass Aorto-Femoral Bypass Axillo-Femoral Bypass With concomitant aorto-iliac disease

13 CFA Endarterectomy May be performed under local anesthesia
Can combine with outflow operation (fem-pop, fem-tibial bypass) Well tolerated – usual LOS 1-2 days Allows for profundaplasty Allows for graft preservation Excellent results >90% patency at 5 years

14 Multiple failed AV grafts L thigh AV graft poor function
40 yo male, ESRD Multiple failed AV grafts L thigh AV graft poor function Gangrene L foot 35 mm gradient

15 with patch angioplasty
Endarterectomy with patch angioplasty

16 83 yo male, former heavy smoker, diabetes, ESRD
2 months of rest pain left foot Nonpalpable femoral and distal pulses ABI 0.2

17

18

19

20

21

22

23

24

25

26

27

28 9 MONTHS LATER: DEVELOPED SIMILAR SYMPTOMS
ABSENT FEMORAL PULSE

29

30 Post scoring balloon angioplasty

31 Combined Surgical and Endovascular Treatment
71 yo male, ESRD, on dialysis, smoker, diabetes Ulceration on forefoot and lower leg Nonpalpable femoral and distal pulses

32

33

34

35

36

37

38 Common Femoral Artery Disease: Percutaneous Endovascular Treatment
Despite its theoretical disadvantages, PEI of the Common Femoral Artery should be part of the overall vascular treatment armamentarium.

39 Common Femoral Artery Disease: Percutaneous Endovascular Treatment
Stenting not an option Avoid dissection POBA may be suboptimal Atherectomy – with distal embolic protection if possible

40

41 Rationale for Atherectomy
Debulking the plaque Change vessel compliance Reduce need for adjunctive stenting May even reduce need for angioplasty Compliance change enables lower pressure adjunctive balloon angioplasty Less dissection Less “uncontrolled damage” ?Better patency?

42 Rationale for Atherectomy
Debulking the plaque Change vessel compliance Reduce need for adjunctive stenting May even reduce need for angioplasty Compliance change enables lower pressure adjunctive balloon angioplasty Less dissection Less “uncontrolled damage” ?Better patency?

43 Rationale for Atherectomy
Debulking the plaque Change vessel compliance Reduce need for adjunctive stenting May even reduce need for angioplasty Compliance change enables lower pressure adjunctive balloon angioplasty Less dissection Less “uncontrolled damage” ?Better patency?

44

45

46

47

48 Conclusion Disease of the common femoral artery poses unique challenges for “conventional” percutaneous endovascular treatment. Surgical treatment, especially endarterectomy, is safe, effective, and quite durable.

49 Newer technology will expand the endovascular options.
Conclusion Endovascular interventions on the common femoral artery can also be successful, sage, and effective in the appropriate patient when performed by the appropriate clinician, with the appropriate tools. Newer technology will expand the endovascular options.

50 Conclusion Ultimately, both surgical and endovascular treatments should be within the toolbox of the experienced and skilled interventionalist.


Download ppt "Michael Siah, M.D. Medstar Georgetown University Hospital"

Similar presentations


Ads by Google